Maria E. Arango

2.7k citations
22 papers · 2.1k · 2 hit papers · h-index 15

Impact in

  • Oncology top 2%
    • Lung Cancer Research Studies
    • HER2/EGFR in Cancer Research
  • Hepatology top 5%
    • Liver physiology and pathology

Papers in

    • Glycosylation and Glycoproteins Research 7
    • HER2/EGFR in Cancer Research 3
    • Cancer-related Molecular Pathways 2

Maria E. Arango

19 papers receiving 2.1k citations

Maria E. Arango's Hit Papers

An Orally Available Small-Molecule Inhibitor of c-Met, PF-2341066, Exhibits Cytoreductive Antitumor Efficacy through Antiproliferative and Antiangiogenic Mechanisms 2007 · 596 citations
5960+6+12Years since publication100200300400500

Peers

Maria E. Arango
Comparison fields: 5 of 87
  • Oncology 886
  • Hepatology 228
  • Pulmonary and Respiratory Medicine 634
  • Molecular Biology 1.1k
  • Pathology and Forensic Medicine 210
Replace Archie Tse with:
Archie Tse United States
Vincenzo Damiano Italy
Dana T. Aftab United States
Fawn Qian United States
Silvia Benvenuti Italy
Masaki Hanibuchi Japan
Cheng‐long Huang Japan
Marie Prewett United States
William J. Slichenmyer United States
Soji Kakiuchi Japan
Maria E. Arango relative to Archie Tse United States Archie Tse's profile →
Citations per field
00.5×1.5×
Archie Tse · 1×
Citations per year

Countries citing papers authored by Maria E. Arango

Since Specialization
Citations

This map shows the geographic impact of Maria E. Arango's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maria E. Arango with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maria E. Arango more than expected).

Fields of papers citing papers by Maria E. Arango

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maria E. Arango. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maria E. Arango. The network helps show where Maria E. Arango may publish in the future.

Co-authors

The 25 scholars most cited alongside Maria E. Arango, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Maria E. Arango Line = papers co-authored together Maria E. Arango links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 22 papers — load more, or switch the sort, to bring in the rest.

#Work
1
An Orally Available Small-Molecule Inhibitor of c-Met, PF-2341066, Exhibits Cytoreductive Antitumor Efficacy through Antiproliferative and Antiangiogenic Mechanisms
Hit paper breakdown →
2007596
2
Cytoreductive antitumor activity of PF-2341066, a novel inhibitor of anaplastic lymphoma kinase and c-Met, in experimental models of anaplastic large-cell lymphoma
Hit paper breakdown →
2007517
3 2008172
4 2002159
5 2002117
6 2001106
7 200294
8 201060
9 201257
10 200945
11
Production and localization of Muc4/sialomucin complex and its receptor tyrosine kinase ErbB2 in the rat lacrimal gland.
200142
12 200241
13 200832
14 201129
15 200218
16 200114
17 20088
18
AG-024322 is a potent and selective multi-targeted CDK inhibitor with broad spectrum anti-proliferative activity
20058
19 20212
20 20230

About Maria E. Arango

Maria E. Arango is a scholar working on Molecular Biology, Oncology, Cell Biology, Radiology, Nuclear Medicine and Imaging and Immunology, having authored 22 papers that have together received 2.1k indexed citations. Recurring topics across this work include Glycosylation and Glycoproteins Research (7 papers), Galectins and Cancer Biology (4 papers), Monoclonal and Polyclonal Antibodies Research (4 papers), Microtubule and mitosis dynamics (3 papers), Proteoglycans and glycosaminoglycans research (3 papers), HER2/EGFR in Cancer Research (3 papers), Liver physiology and pathology (2 papers) and Cancer-related Molecular Pathways (2 papers). The work is most often cited by research in Oncology (886 citations), Hepatology (228 citations), Pulmonary and Respiratory Medicine (634 citations), Molecular Biology (1.1k citations) and Pathology and Forensic Medicine (210 citations). Maria E. Arango has collaborated with scholars based in United States, United Kingdom and Portugal. Frequent co-authors include James G. Christensen, Gerrit Los, Kermit L. Carraway, Joseph H. Lee, Shinji Yamazaki, Qiuhua Li, Helen Y. Zou, Barbara Mroczkowski, Gordon Alton and Scott R. McDonnell. Their work appears in journals such as Molecular Cancer Therapeutics, Clinical Cancer Research, Cancer Research, Oncogene and Tissue and Cell.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact